// App-Quantinova.ai

803 : A20 and its repressor DREAM expression govern susceptibility to fibrosis in systemic sclerosis

Researchers

Presenter

  • W. Wang

Principal Investigators

  • B. Claudia Schock

  • H. Abdala-Valencia

  • B. Jeong

  • S. Bale

  • R.B. Christmann

  • R. Marangoni

  • S. Berdnikovs

  • E. Herzog

  • J. Varga

  • S. Bhattacharyya

Medical Centers

  • Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

  • Queen's University Belfast, Belfast, United Kingdom

  • Spirogen/MedImmune, London, United Kingdom.

  • Yale University, New Haven, Connecticut, United States

  • Dept. of Medicine, Northwestern University, Chicago, Illinois, United States

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Scleroderma

Biomarkers

  • Adiponectin

Drug/Treatment

  • Repaglinide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved